(ATRO) Astronics - NASDAQ
Sector: Industrials | Industry: Aerospace & Defense | Exchange: NASDAQ (USA) | Market Cap: 3.398m USD | Total Return: 182.5% in 12m
Avg Turnover: 42.4M
Qual. Beats: -1
Rev. Trend: -5.8%
Qual. Beats: 0
Warnings
P/E ratio 77.7
Tailwinds
Shakeout, Rs Leader, Idiosyncratic Leader, Tailwind, Confidence
Astronics Corporation (NASDAQ: ATRO) is a diversified manufacturer serving the global aerospace, defense, and electronics sectors. Headquartered in East Aurora, New York, the company operates through two primary divisions: Aerospace and Test Systems. The Aerospace segment provides critical components including power generation, lighting, and avionics to commercial airlines, military branches, and original equipment manufacturers (OEMs).
The Test Systems segment focuses on automated testing infrastructure and simulation devices for mass transit and defense contractors. Within the aerospace supply chain, the business model relies heavily on long-term OEM contracts and the aftermarket maintenance cycle, where proprietary components often require specialized servicing. As global air traffic recovers, demand for in-flight connectivity and cabin power systems-two areas of company focus-historically correlates with airline fleet modernization efforts.
Investors can evaluate the companys valuation metrics and historical performance trends on ValueRay to gain deeper insights. Founded in 1968, Astronics maintains an international footprint with operations spanning North America, Europe, and Asia.
- Commercial aircraft production rates at Boeing and Airbus drive OEM component demand
- Airline passenger cabin upgrades increase retrofit orders for power and lighting systems
- Department of Defense procurement cycles dictate Test Systems segment revenue growth
- Supply chain constraints and labor costs impact manufacturing margins and delivery timelines
- Certification delays for new aircraft programs postpone revenue recognition for avionics systems
| Net Income: 45.4m TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.03 > 0.02 and ΔFCF/TA -2.76 > 1.0 |
| NWC/Revenue: 35.06% < 20% (prev 33.65%; Δ 1.41% < -1%) |
| CFO/TA 0.09 > 3% & CFO 65.5m > Net Income 45.4m |
| Net Debt (411.5m) to EBITDA (115.1m): 3.57 < 3 |
| Current Ratio: 2.97 > 1.5 & < 3 |
| Outstanding Shares: last quarter (38.2m) vs 12m ago -11.02% < -2% |
| Gross Margin: 30.72% > 18% (prev 25.63%; Δ 5.09% > 0.5%) |
| Asset Turnover: 125.8% > 50% (prev 123.3%; Δ 2.58% > 0%) |
| Interest Coverage Ratio: 7.91 > 6 (EBIT TTM 93.0m / Interest Expense TTM 11.7m) |
| A: 0.42 (Total Current Assets 468.6m - Total Current Liabilities 157.7m) / Total Assets 747.1m |
| B: 0.29 (Retained Earnings 216.7m / Total Assets 747.1m) |
| C: 0.13 (EBIT TTM 93.0m / Avg Total Assets 704.7m) |
| D: 0.28 (Book Value of Equity 161.7m / Total Liabilities 585.4m) |
| Altman-Z'' = 4.85 = AA |
| DSRI: 1.03 (Receivables 217.0m/194.0m, Revenue 886.8m/816.3m) |
| GMI: 0.83 (GM 25.63% / 30.72%) |
| AQI: 1.00 (AQ_t 0.17 / AQ_t-1 0.17) |
| SGI: 1.09 (Revenue 886.8m / 816.3m) |
| TATA: -0.03 (NI 45.4m - CFO 65.5m) / TA 747.1m) |
| Beneish M = -3.09 (Cap -4..+1) = AA |
As of June 12, 2026, the stock is trading at USD 94.80 with a total of 1,271,800 shares traded.
Over the past week, the price has changed by +8.55%,
over one month by +25.08%,
over three months by +29.53% and
over the past year by +182.48%.
Astronics has received a consensus analysts rating of 3.33. Therefore, it is recommended to hold ATRO.
- StrongBuy: 0
- Buy: 1
- Hold: 2
- Sell: 0
- StrongSell: 0
| Analysts Target Price | 91.4 | -3.6% |
P/E Trailing = 77.7049
P/E Forward = 27.1739
P/S = 3.8313
P/B = 21.0119
P/EG = 1.4638
Revenue TTM = 886.8m USD
EBIT TTM = 93.0m USD
EBITDA TTM = 115.1m USD
Long Term Debt = 334.9m USD (from longTermDebt, last quarter)
Short Term Debt = 5.99m USD (from shortTermDebt, last quarter)
Debt = 423.3m USD (from shortLongTermDebtTotal, last quarter) + Leases 44.2m
Net Debt = 411.5m USD (calculated: Debt 423.3m - CCE 11.9m)
Enterprise Value = 3.81b USD (3.40b + Debt 423.3m - CCE 11.9m)
Interest Coverage Ratio = 7.91 (Ebit TTM 93.0m / Interest Expense TTM 11.7m)
EV/FCF = 153.8x (Enterprise Value 3.81b / FCF TTM 24.8m)
FCF Yield = 0.65% (FCF TTM 24.8m / Enterprise Value 3.81b)
FCF Margin = 2.79% (FCF TTM 24.8m / Revenue TTM 886.8m)
Net Margin = 5.12% (Net Income TTM 45.4m / Revenue TTM 886.8m)
Gross Margin = 30.72% ((Revenue TTM 886.8m - Cost of Revenue TTM 614.4m) / Revenue TTM)
Gross Margin QoQ = 32.58% (prev 33.31%)
Tobins Q-Ratio = 5.10 (Enterprise Value 3.81b / Total Assets 747.1m)
Interest Expense / Debt = 2.77% (Interest Expense 11.7m / Debt 423.3m)
Taxrate = 2.55% (1.19m / 46.6m)
NOPAT = 90.6m (EBIT 93.0m * (1 - 2.55%))
Current Ratio = 2.97 (Total Current Assets 468.6m / Total Current Liabilities 157.7m)
Debt / Equity = 2.62 (Debt 423.3m / totalStockholderEquity, last quarter 161.7m)
Debt / EBITDA = 3.57 (Net Debt 411.5m / EBITDA 115.1m)
Debt / FCF = 16.61 (Net Debt 411.5m / FCF TTM 24.8m)
Total Stockholder Equity = 170.6m (last 4 quarters mean from totalStockholderEquity)
RoA = 6.44% (Net Income 45.4m / Total Assets 747.1m)
RoE = 26.60% (Net Income TTM 45.4m / Total Stockholder Equity 170.6m)
RoCE = 18.39% (EBIT 93.0m / Capital Employed (Equity 170.6m + L.T.Debt 334.9m))
RoIC = 15.53% (NOPAT 90.6m / Invested Capital 583.6m)
WACC = 9.15% (E(3.40b)/V(3.82b) * Re(9.95%) + D(423.3m)/V(3.82b) * Rd(2.77%) * (1-Tc(0.03)))
Discount Rate = 9.95% (= CAPM, Blume Beta Adj.)
Shares (quarterly) Correlation: 46.67 | Cagr: 4.15%
[DCF] Terminal Value 70.17% ; FCFF base≈31.0m ; Y1≈27.1m ; Y5≈21.9m
[DCF] Fair Price = N/A (negative equity: EV 311.2m - Net Debt 411.5m = -100.3m; debt exceeds intrinsic value)
EPS Correlation: N/A | EPS CAGR: N/A | SUE: -4.0 | # QB: -1
Revenue Correlation: -5.79 | Revenue CAGR: -0.99% | SUE: 0.44 | # QB: 0
EPS current Quarter (2026-06-30): EPS=0.67 | Chg30d=N/A | Revisions=+50% | Analysts=4
EPS next Quarter (2026-09-30): EPS=0.71 | Chg30d=N/A | Revisions=+25% | Analysts=4
EPS current Year (2026-12-31): EPS=2.71 | Chg30d=N/A | Revisions=+43% | GrowthEPS=+34.8% | GrowthRev=+14.6%
EPS next Year (2027-12-31): EPS=3.12 | Chg30d=-0.56% | Revisions=+14% | GrowthEPS=+15.3% | GrowthRev=+7.8%
[Analyst] Revisions Ratio: +50%